The collagen receptor discoidin domain receptor 1 (DDR1) induces immune exclusion by promoting collagen fiber alignment; therefore, treatment with a DDR1-neutralizing antibody that disrupts collagen fiber alignment increases immune infiltration and inhibits tumor growth in triple-negative breast cancer [121]. The gene discussed is DDR1; the disease is neoplasm.